doi: 10.1136/bmj.2.5459.453.
CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION
- PMID: 14314911
- PMCID: PMC1845864
- DOI: 10.1136/bmj.2.5459.453
Item in Clipboard
CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION
Br Med J.
.
No abstract available
Similar articles
-
CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY.Practitioner. 1964 Nov;193:698-702. Practitioner. 1964. PMID: 14225574 No abstract available.
-
OBESITY TREATMENT OF COMPLICATED AND UNCOMPLICATED CASES WITH CHLORPHENTERMINE HYDROCHLORIDE.Ind Med Surg. 1965 Jun;34:490-2. Ind Med Surg. 1965. PMID: 14308330 No abstract available.
-
[EFFECT OF PHENYLACETIC ACID ON URINARY EXCRETION OF 17-HYDROXYCORTICOSTEROIDS, 17-KETOSTEROIDS AND 17-KETOGENIC STEROIDS].Endokrynol Pol. 1964 Jan-Feb;15:89-99. Endokrynol Pol. 1964. PMID: 14205595 Polish. No abstract available.
-
17-Ketogenic steroid excretion in obese children before and after weight reduction.Br Med J. 1958 Mar 22;1(5072):686-8. doi: 10.1136/bmj.1.5072.686. Br Med J. 1958. PMID: 13510770 Free PMC article. No abstract available.
-
ADVANCES IN CLINICAL STEROID METHODOLOGY: A REVIEW.Ala J Med Sci. 1964 Jul;1:278-90. Ala J Med Sci. 1964. PMID: 14193528 Review. No abstract available.
Cited by
-
Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects.Future Med Chem. 2020 Oct;12(20):1865-1884. doi: 10.4155/fmc-2019-0361. Epub 2020 Oct 12. Future Med Chem. 2020. PMID: 33040605 Free PMC article. Review.
-
Update on Pediatric Anti-obesity Medications-Current Landscape and Approach to Prescribing.Curr Obes Rep. 2024 Jun;13(2):295-312. doi: 10.1007/s13679-024-00566-z. Epub 2024 Apr 30. Curr Obes Rep. 2024. PMID: 38689134 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources